Reuters logo
BRIEF-Livzon Pharma expects H1 net profit to rise 20-30 pct y/y
July 11, 2017 / 8:33 AM / 4 months ago

BRIEF-Livzon Pharma expects H1 net profit to rise 20-30 pct y/y

July 11 (Reuters) - Livzon Pharmaceutical Group Inc

* Says it expects H1 net profit to rise 20-30 percent y/y to 490.9-531.8 million yuan ($72.20-$78.21 million)

Source text in Chinese: bit.ly/2t8Me0y

Further company coverage: ($1 = 6.7993 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below